Al resection and nonetheless lack a clear survival advantage in comparison with
Al resection and still lack a clear survival benefit when compared with re-irradiation in adults with relapsed HGG [45, 46]. Anti-GD2-directed CAR-T cell application for DMG could possibly be an additional future selection, and local delivery of HER2-directed CAR-T cells is at present becoming tested in youngsters with refractory/relapsed CNS tumors (BrainChild-01, NCT0350099) [15, 47]. […]